These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6548099)

  • 1. Endogenous digoxin-like substance(s) and combined hepatic and renal failure.
    Gault MH; Vasdev SC; Longerich LL
    Ann Intern Med; 1984 Oct; 101(4):567-8. PubMed ID: 6548099
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of assay methodologies and interferences on the interpretation of digoxin concentrations.
    Fitzsimmons WE
    Drug Intell Clin Pharm; 1986; 20(7-8):538-42. PubMed ID: 3755675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interference of digoxin-like immunoreactive substance in the analysis of digoxin in pulmonary pathology: preliminary results].
    Romano L; Zofra S; Imperato G; Adorno V; Maglione A
    Arch Monaldi; 1985; 40(3-4):157-64. PubMed ID: 3842060
    [No Abstract]   [Full Text] [Related]  

  • 4. Bile salts as endogenous digitalis like factors.
    Vasdev SC; Longerich LL; Ittel TH; Johnson E; Barrowman JA; Gault MH
    Clin Invest Med; 1986; 9(3):201-8. PubMed ID: 3019598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous digoxin-like immunoreactive substances eliminated from serum samples from patients with liver disease by the EMIT column digoxin assay.
    Kulaots IA; Pudek MR; Seccombe DW
    Clin Chem; 1987 Aug; 33(8):1490-1. PubMed ID: 3301074
    [No Abstract]   [Full Text] [Related]  

  • 6. [Digoxin-like material in liver disease].
    Shilo L; Shapiro MS; Shenkman L
    Harefuah; 1988 Mar; 114(5):224-5. PubMed ID: 3366400
    [No Abstract]   [Full Text] [Related]  

  • 7. Digoxin-like immunoreactive substance (DLIS) in liver disease: comparison of clinical and laboratory parameters in patients with and without DLIS.
    Gervais A; Nanji AA; Greenway DC; McLean W
    Drug Intell Clin Pharm; 1987 May; 21(5):450-2. PubMed ID: 3582173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digoxin radioimmunoassay that does not detect digoxin-like substance in serum of newborns, infants, or patients with renal failure.
    Witherspoon L; Shuler S; Neely H; Sonnemaker R; Alyea K; Gilbert S
    Clin Chem; 1987 Mar; 33(3):420. PubMed ID: 3815819
    [No Abstract]   [Full Text] [Related]  

  • 9. Digoxin-like immunoreactive substances in the plasma of intensive care unit patients: relationship to organ dysfunction.
    Howarth DM; Sampson DC; Hawker FH; Young A
    Anaesth Intensive Care; 1990 Feb; 18(1):45-52. PubMed ID: 2159733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digoxin-like immunoreactivity, endogenous cardiac glycoside-like factor(s) and natriuretic hormone: more than a hypothesis.
    Clerico A
    J Nucl Med Allied Sci; 1987; 31(4):341-56. PubMed ID: 2832557
    [No Abstract]   [Full Text] [Related]  

  • 11. [Developement and quality control of a radioimmunoassay for measurement of endogenous digoxin].
    Baz MJ; Vargas F; Haro JM; Castillo MA; Jódar E; Andrade JL; García del Río C
    Rev Esp Fisiol; 1990 Dec; 46(4):385-91. PubMed ID: 2099536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digoxin-like immunoreactive substance in renal failure: a reappraisal.
    Greenway DC; Nanji AA
    Nephron; 1986; 44(2):108-10. PubMed ID: 3774074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in apparent serum digitalis-like factor levels with different digoxin antibodies. The "immunochemical fingerprint".
    Naomi S; Graves S; Lazarus M; Williams GH; Hollenberg NK
    Am J Hypertens; 1991 Oct; 4(10 Pt 1):795-801. PubMed ID: 1747212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher values for digitalis-like factors with TDx Digoxin II.
    Gault MH; Vasdev S; Longerich L
    Clin Chem; 1986 Oct; 32(10):2000-1. PubMed ID: 3757253
    [No Abstract]   [Full Text] [Related]  

  • 15. Digoxin-like immunoreactive substances and bile acids in the serum of patients with liver disease.
    Pudek MR; Seccombe DW; Humphries K
    Clin Chem; 1986 Oct; 32(10):2005-6. PubMed ID: 3757258
    [No Abstract]   [Full Text] [Related]  

  • 16. [Endogenous digoxin-like substance level in essential arterial hypertension, renal failure and acromegaly].
    Soszyński P; Słowińska-Srzednicka J; Wierzbicki M
    Pol Arch Med Wewn; 1988 Jan; 79(1):20-5. PubMed ID: 3275165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous digoxin-like material in patients with liver disease.
    Shilo L; Shapiro MS; Dolev S; Shenkman L
    Ann Intern Med; 1985 Oct; 103(4):643. PubMed ID: 3839990
    [No Abstract]   [Full Text] [Related]  

  • 18. Assay for digoxin-like immunoreactive substance--loss of sensitivity.
    Ho CS; Swaminathan R
    Clin Chem; 1988 Dec; 34(12):2604. PubMed ID: 3197324
    [No Abstract]   [Full Text] [Related]  

  • 19. A physician's office-based digoxin assay (Seralyzer) evaluated for interference by endogenous digoxin-like immunoreactive factors.
    Matheke ML; Valdes R
    Ann Clin Lab Sci; 1989; 19(3):168-74. PubMed ID: 2658726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digitoxin antibody cross-reactivity and evaluation of potential candidates for circulating digitalis-like immunoreactive factor.
    Graves SW; Naomi S; Williams GH; Hollenberg NK
    Clin Chem; 1994 Oct; 40(10):1977-8. PubMed ID: 7923784
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.